A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors	neoplasm	Recruiting	Phase 1 / Phase 2	2024-12-19		NCT05615974

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
LaNova Medicines Limited	13

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tongren Hospital, CMU	Beijing	China	2
Fudan University Shanghai Cancer Center	Shanghai	China	128
Linyi Cancer Hospital	Linyi	China	22
Sun Yat-Sen University Cancer Center	Guangzhou	China	113
Zhongnan Hospital of Wuhan University	Wuhan	China	34

Clinical trials